Discussed On
Episodes
Pharmaceutical Executive · May 13, 2026
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
PROTAC Technology and Protein DegradationGLP-1 Receptor Agonist TherapiesObesity Treatment and Weight Loss MaintenanceBiotech Licensing AgreementsPharmaceutical Development Milestones
View Analysis